Why the study?
Conflicting evidence links both pathological NO overproduction and attenuated NO bioavailability to HFpEF, prompting investigation of dysregulated NO signaling and NO-based dual therapy.
Does combination sodium nitrite and hydralazine therapy attenuate HFpEF severity in a 2-hit murine model?
Population
Nine-week-old male C57BL/6 N mice (n=15 per group) in a 2-hit HFpEF model
Comparison
Sodium nitrite plus hydralazine vs vehicle (normal saline)
Design
Randomized preclinical animal study
Follow-up
10 weeks
Authors
Loading...
Targeting NO pathways in HFpEF should not yet change practice; leaves open optimal iNOS or eNOS targets.
Does combination sodium nitrite and hydralazine therapy attenuate HFpEF severity in a 2-hit murine model?
In a murine model of HFpEF, combination therapy with sodium nitrite and hydralazine attenuated disease severity by restoring NO bioavailability and reducing oxidative stress.
LaPenna et al. (2023) studied this question.